Project Scope
Project Scope |
This group is designed to serve as an open-source platform for addressing queries related to real-world data (RWD). We aim to create an environment similar to Stack Overflow, where you can receive answers to your questions. |
Problem Statement |
Every organisation has internal documents of learnings and best practices for conducting research with real-world data. This could take the form of database quirks, standard cohort definitions and preferred algorithms. There is currently no open-source alternative to the internal documents, which leads to duplicated errors, slower learning at the individual level and slower advancement of real-world evidence at the industry level. |
Problem Impact |
Having an open-source option for these learnings to be recorded and shared will lead to less duplication of effort, faster evolution of the real-world evidence space, and ultimately better insights for participants and patients. Stakeholders include data vendors, pharma and any other entity that uses real-world data. |
Project Leads | |
---|---|
David Hood (, Axtria) | |
Katie Warren (Nicola Newton, PHUSE Project Assistant) |
| ||||||
---|---|---|---|---|---|---|
|
Resources |
---|
A collection of frequently asked questions about using Real World Evidence has been compiled by the team. Check out the Real World Evidence Guidance Q&A page to see some of the teams' responses and the schedule of upcoming questions. |
Objectives & Deliverables | Timelines |
---|---|
Project kick off | Q2 2023 |
Create 5 seed example Q&A posts | Q2 2023 |
Abstract to be posted on PHUSE education website to raise awareness of this forum | Q3 2023 |
Email/social media campaign to raise awareness | Q3 2023 |
Publish questions | Ongoing |
Starting Q3 2023, deliverables will be ongoing. The team will be responding to questions which are posted and may begin as soon as the location (website) is confirmed, ideally by Q2 2023. |
Status | ||||
---|---|---|---|---|
|
New project approved. Calling for volunteers.
Evidera
Cheryl Grandinetti
FDA
D'dra Octaviano
Alnylam
Bayer
Bayer
Softworld
Pfizer
Novonordisk
Janssen Research & Development
GSK